Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-035920
Filing Date
2014-05-21
Accepted
2014-05-21 17:26:46
Documents
1
Period of Report
2014-05-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4763
  Complete submission text file 0001209191-14-035920.txt   6176
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Issuer) CIK: 0001373707 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EXCEL VENTURE MANAGEMENT, LLC 800 BOYLSTON ST., STE 2825 BOSTON MA 02199
Business Address
Gullans Steven R. Ph.D. (Reporting) CIK: 0001571997 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35837 | Film No.: 14861641